中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
MeSH:(Transglutaminases/*antagonists )

1.A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor.

Joonhong SOHN ; Ju Byung CHAE ; Sun Young LEE ; Soo Youl KIM ; June Gone KIM

Korean Journal of Ophthalmology 2010;24(1):29-34

2.Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine.

Ju Hong JEON ; Hye Jin LEE ; Gi Yong JANG ; Chai Wan KIM ; Dong Myung SHIN ; Sung Yup CHO ; Eui Ju YEO ; Sang Chul PARK ; In Gyu KIM

Experimental & Molecular Medicine 2004;36(6):576-581

3.Effects of Transglutaminase 2 Inhibition on Ventilator-Induced Lung Injury.

In Bum SUH ; Dae Wui YOON ; Won Oak OH ; Eun Joo LEE ; Kyung Hoon MIN ; Gyu Young HUR ; Seung Heon LEE ; Sung Yong LEE ; Sang Yeub LEE ; Chol SHIN ; Jae Jeong SHIM ; Kwang Ho IN ; Kyung Ho KANG ; Je Hyeong KIM

Journal of Korean Medical Science 2014;29(4):556-563

4.Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.

Jae Heon JEONG ; Byoung Chul CHO ; Hyo Sup SHIM ; Hye Ryun KIM ; Sun Min LIM ; Se Kyu KIM ; Kyung Young CHUNG ; S M Bakhtiar Ul ISLAM ; Jae Jin SONG ; Soo Youl KIM ; Joo Hang KIM

Journal of Korean Medical Science 2013;28(7):1005-1014

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO